GUCA2B and gastrointestinal disease: Thus, the demonstration of gene expression pattern of guanylin, uroguanylin and GC-C receptors in the horse intestine could open new ways for the therapeutic approach to horse gastrointestinal diseases by GC-C agonist, offering the advantage of accelerating transit together with pain control.